The Visiomed Group’s story begins in 2007 when Eric Sebban, the founder and CEO, launched ThermoFlash®, the first electronic non-contact infrared medical thermometer. Its commercialisation marks the beginning of the Visiomed Group’s rise in France and abroad.
Launch of ThermoFlash®: An innovative breakthrough dedicated to healthcare.
Start of large international pandemics (H1N1, then Ebola in 2014) – ThermoFlash® is deployed throughout the world (WHO, large NGOs, French and American armed forces, airports and local health authorities).
Initial public offering on the NYSE Alternext in Paris. ISIN: FR001106769
The Visiomed Group has close to 100 innovative products in its self-diagnosis and well-being portfolio.
Launch of the BewellConnect “My personal health assistant”, a unique range of connected health devices linked to a single mobile app.
The Visiomed Group and Orange introduce MyHealthbox®, an innovative connected solution for outpatient care without a smartphone.
Already established in 35 countries, the Visiomed Group opens its American subsidiary BewellConnect® Corp. in Boston (MA), which obtains FDA approval within the year. One year later, its Brazilian subsidiary opens in Maringá.
MyECG, The 1st wireless-connected pocket electrocardiograph takes top prize at the CES in Las Vegas.
Launch of two premium services which complete the BewellConnect range of devices : BewellCheck-Up et MyDoc.
Signing of a worldwide commercial and technological partnership between the Visiomed Group and Huawei to create a truly integrated, connected and secured product offer for both patients and health professionals.
A major distribution contract is signed in the United States between BewellConnect® Corp. and Henry Schein Medpod
BewellConnect® presents its 3 latest innovations at the CES in Las Vegas: VisioCheck, the first connected mobile telemedicine station in the world. This versatile telemedicine tool was designed to facilitate the daily medical practice of health professionals. The Life Assistant from SoftBank Robotics named Pepper is equipped with BewellConnect® solutions (connected health services and medical devices), via a partnership with Robotopi. Visiomed launches BewellConnect®/MAJORD’HOME, the connected smart TV especially for in-home care for the elderly.
Cegedim and Visiomed Group push forward on developing their partnership and sign a strategic partnership agreement
Visiomed Group, Docapost, an affiliate of the La Poste group, and Huawei, a leader in the telecommunications and new technology sector, sign a strategic and technological partnership agreement to accelerate the use of e-healthcare and telemedicine in France.
BewellConnect continues to grow in Italy and signs two commercial partnerships with Europ Assistance and Cezare Pozzo, a private healthcare insurer, to make its services available to their policyholders.
BewellCheck-up receives European medical certification
The WHO selects Visiomed Group as its official thermometry solutions provider
Visiomed Group receives the Innovation Award in the Health category at the 2017 Salon des Maires and local authorities for VisioCheck®.
BewellConnect® Selects SCC and signs strategic partnership to organize the deployment of telemedicine.
BewellConnect® presents at CES new e-health and telemedicine solutions that now cover the entire healthcare journey thanks to BewellXpert, its new telemonitoring and care coordination platform.
BewellConnect opens the market for US government orders through a distribution agreement with Janz Corporation.
BewellConnect announces the launch of the teleconsultation station VisioCheck® in pharmacies.
Presentation of the strategic plan “Confidence and Growth” to create a profitable growth dynamic by 2020
Completion of the acquisition of two centuries-old brands of Omega Pharma Laboratories to accelerate the development of Visiomed Laboratories.
First pharmacy installations of the mobile and connected teleconsultation stations developed based on BewellConnect’s leading product, VisioCheck®
The FDA grants VisioCheck® the 510 (k) certification as well as it registration, authorizing the marketing in the United-States of the world’s first mobile connected telemedicine station under 300g.